BRCA2 and breast cancer: Here we report the functional characterization of a novel de novo BRCA2 splice site mutation located in the intervening sequence (IVS) of exon 21 (nucleotide 8982+1 G→A/c.8754+1 G→A) in a Danish breast cancer patient with a family history of breast cancer.